Amyris files to sell 65.2M shares of common stock for holders 17:2807/1007/10/20
|Over a week ago|
Amyris, AB Mauri North America announce multi-year agreement » 08:3806/2206/22/20
Amyris and AB Mauri North…
Amyris and AB Mauri North America jointly announced an exclusive multi-year agreement for the sale and purchase of Amyris' Purecane RebM zero-calorie sweetener for baking applications. This partnership is expected to transform the industrial baking sector in the US, Mexico and Canada markets by enabling AB Mauri's customers to produce reduced sugar baked goods with no loss of flavor, texture or product appeal. The collaboration signifies a promising beginning and catalyst for future growth opportunities for the Purecane brand, which launched in December 2019 following Amyris' introduction of its sweetener ingredient in December 2018.
|Over a month ago|
Amyris receives GRAS validation for new health and nutrition ingredient » 08:3605/1405/14/20
Amyris' first health…
Amyris' first health and nutrition ingredient received a validation by a unanimous Panel of Medical Experts as Generally Recognized As Safe, or GRAS. Following this successful validation, Amyris will submit an application for FDA GRAS approval of this ingredient. The ingredient is currently not being named due to partner's requirements.
Amyris backs FY20 revenue growth view of 44%, consensus $246.44M » 08:3605/0805/08/20
Gross Margin is expected…
Gross Margin is expected to operate at greater than 60% of sales due to improved sales mix and lower unit costs. Adjusted EBITDA is expected to turn positive during Q4.
Amyris reports Q1 adj. EPS (28c), consensus (19c) » 08:3405/0805/08/20
Reports Q1 revenue $29M,…
Reports Q1 revenue $29M, consensus $34.51M. CEO John Melo stated, "We are pleased with our Q1 results for what is typically our lowest sales quarter of the year due to seasonality. We have seen limited impact to our business performance from COVID-19. During the month of April we delivered our best single month of consumer product sales. We are experiencing significant demand for our ingredients into cleaning products and personal care products. We are encouraged by the growth in our top and bottom-line performance and see continued opportunity with our strong portfolio of branded consumer products and functional ingredients. Our focus on higher margin product sales and reducing unit costs by adapting our supply chain are delivering strong results. At our current performance we expect to achieve positive operating cash performance by Q4. We remain committed to our current guidance and will update our view on the year as we get more visibility."
Amyris receives approval for Purecane from Brazil and Canada regulators » 08:3104/2004/20/20
Amyris announced that it…
Amyris announced that it has received approval from both Brazilian and Canadian regulators to expand its distribution of its fermented sugarcane Reb M, branded as Purecane zero calorie sweetener in the US to both of these countries. Purecane Brand Sweetener, also known as fermented sugarcane Reb M, is a no calorie and zero glycemic sweetener that can be used as part of a healthy diet to reduce the intake of sugar, calories and carbohydrates.
|Over a quarter ago|
Amyris says sales of Pipette branded hand sanitizer off to strong start » 07:3204/1304/13/20
Amyris announced the full…
Amyris announced the full market launch and sales of its Pipette branded hand sanitizer as of April 9th. Since its launch, the product has seen demand well above expectations prompting the search for expanded supply capacity with a short-term goal of reaching 1M units monthly. During the first three days after launch, Amyris sold in excess of $1.5M of hand sanitizer and continues to experience very strong demand. The company is donating 21,000 family size 32oz units to front line health care workers battling the COVID-19 crisis, including UCSF Benioff Children's Hospital, Kaiser Permanente, Alameda Hospital, Fairmont Hospital & Rehabilitation Center, Highland Hospital, John George Psychiatric Hospital, San Leandro Hospital, UCLA, Cedars Sinai; and Elmhurst Hospital, Mount Sinai, St Francis Hospital and New York Presbyterian Hospital. Amyris has already donated hand sanitizer to corporations, like Bloom Energy, which is refurbishing much needed ventilators for hospitals.
Largest borrow rate increases among liquid names » 08:4504/0604/06/20
CLVS, UPRO, JNK, I, AMRS, SGMS, RSX, EWC, MNK
Latest data shows the…
Latest data shows the largest indicative borrow rate increases among liquid option names include: Clovis (CLVS) 79.78% +1.85, ProShares UltraPro S&P 500 (UPRO) 3.49% +1.58, SPDR Barclays Capital High Yield Bond (JNK) 2.06% +0.51, Intelsat (I) 8.11% +0.35, Amyris (AMRS) 10.84% +0.30, Scientific Games (SGMS) 0.74% +0.29, Market Vectors Russia (RSX) 3.52% +0.28, iShares Canada (EWC) 1.44% +0.28, Direxion Daily 20 plus Year Treasury Bull 3X Shares (TMF) 4.07% +0.15, and Mallinckrodt (MNK) 66.18% +0.08.
Amyris announces initial production of hands sanitizer at Allure Labs » 08:3203/3103/31/20
Amyris announced that…
Amyris announced that initial production of its hand sanitizer has started with Allure Labs as its contract manufacturing and packaging partner. Amyris has also successfully replenished its popular baby wipes that have been out of stock in most channels as fast as they restock. Last week, Amyris announced the launch of a new, safe and clean Pipette Baby branded hand sanitizer - that can be used by everyone - to help combat COVID-19. The company has rapidly scaled its manufacturing and supply chain to respond to the strong demand received since the announcement was made. Amyris is also announcing the successful restocking of its baby wipes that was sold out across most sales channels. The company has increased production orders to meet the increased need of consumers.
Largest borrow rate increases among liquid names » 08:4503/2703/27/20
OVV, FCEL, AMRS, PD, UVXY, BZUN, FSM, SSO, VGK
Latest data shows the…
Latest data shows the largest indicative borrow rate increases among liquid option names include: Precigen (PGEN) 24.59% +1.87, Ovintiv (OVV) 49.23% +0.85, FuelCell (FCEL) 14.60% +0.23, Amyris (AMRS) 15.66% +0.20, PagerDuty (PD) 0.76% +0.19, ProShares Ultra VIX Short Term Futures (UVXY) 3.74% +0.16, Baozun (BZUN) 2.06% +0.16, Fortuna Silver Mines (FSM) 0.71% +0.16, ProShares Ultra S&P 500 (SSO) 1.95% +0.14, and Vanguard MSCI Europe (VGK) 0.84% +0.13.